DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
13-DEOXYDOXORUBICIN
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
13-DEOXYDOXORUBICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
1S9VO1DQG5
Molecule Type:
Small molecule
Molecular Formula:
C27H31NO10
Molecular Weight:
529.54
AlogP:
0.82
PSA:
189.0
HBD:
6.0
HBA:
#RotB:
5.0
Source:
POLYCARBOPHIL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Bulk forming laxative
POLYCARBOPHIL
×
Maximum Phase:
2
First Approval:
None
UNII:
W25LM17A4W
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NIRAPARIB TOSYLATE MONOHYDRATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NIRAPARIB TOSYLATE MONOHYDRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OROTIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
OROTIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
61H4T033E5
Molecule Type:
Small molecule
Molecular Formula:
C5H4N2O4
Molecular Weight:
156.1
AlogP:
-1.24
PSA:
103.02
HBD:
3.0
HBA:
#RotB:
1.0
Source:
ASLAN-003
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Dihydroorotate dehydrogenase inhibitor
ASLAN-003
×
Maximum Phase:
2
First Approval:
None
UNII:
I58WE41H6X
Molecule Type:
Small molecule
Molecular Formula:
C19H14F2N2O3
Molecular Weight:
356.33
AlogP:
4.48
PSA:
71.45
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CENTHAQUINE
2
Small molecule
Investigational
Unknown
Unknown
Shock
Unknown
CENTHAQUINE
×
Maximum Phase:
2
First Approval:
None
UNII:
QD4VI0J9T5
Molecule Type:
Small molecule
Molecular Formula:
C22H25N3
Molecular Weight:
331.46
AlogP:
3.91
PSA:
19.37
HBD:
0.0
HBA:
#RotB:
4.0
Source:
R-343
2
Small molecule
Investigational
Unknown
Unknown
Asthma
Tyrosine-protein kinase SYK inhibitor
R-343
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H17F3N6O4
Molecular Weight:
474.4
AlogP:
3.15
PSA:
126.5
HBD:
4.0
HBA:
#RotB:
7.0
Source:
DEXPRAMIPEXOLE DIHYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis
Unknown
DEXPRAMIPEXOLE DIHYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
795J01AE70
Molecule Type:
Small molecule
Molecular Formula:
C10H21Cl2N3OS
Molecular Weight:
302.27
AlogP:
1.58
PSA:
50.94
HBD:
2.0
HBA:
#RotB:
3.0
Source:
MANNOSE-6-PHOSPHATE
2
Small molecule
Investigational
Unknown
Unknown
Skin Abnormalities; Wounds and Injuries
Unknown
MANNOSE-6-PHOSPHATE
×
Maximum Phase:
2
First Approval:
None
UNII:
C77UQ006XD
Molecule Type:
Small molecule
Molecular Formula:
C6H13O9P
Molecular Weight:
260.13
AlogP:
-3.1
PSA:
156.91
HBD:
6.0
HBA:
#RotB:
3.0
Source:
SEPETAPROST
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SEPETAPROST
×
Maximum Phase:
2
First Approval:
None
UNII:
79O7855J4G
Molecule Type:
Small molecule
Molecular Formula:
C26H36F2O6
Molecular Weight:
482.56
AlogP:
4.17
PSA:
85.22
HBD:
2.0
HBA:
#RotB:
10.0
Source:
BMS-813160
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Pancreatic Ductal; Hyperplasia; Diabetic Nephropathies; Neoplasms
C-C chemokine receptor type 2 antagonist
BMS-813160
×
Maximum Phase:
2
First Approval:
None
UNII:
83U7957287
Molecule Type:
Small molecule
Molecular Formula:
C25H40N8O2
Molecular Weight:
484.65
AlogP:
2.25
PSA:
116.55
HBD:
3.0
HBA:
#RotB:
5.0
Source:
DEOXYCYTIDINE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms
Unknown
DEOXYCYTIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
0W860991D6
Molecule Type:
Small molecule
Molecular Formula:
C9H13N3O4
Molecular Weight:
227.22
AlogP:
-1.53
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
2.0
Source:
GSK2798745
2
Small molecule
Investigational
Unknown
Unknown
Cough; Macular Edema; Heart Failure; Pulmonary Edema
Transient receptor potential cation channel subfamily V member 4 antagonist
GSK2798745
×
Maximum Phase:
2
First Approval:
None
UNII:
63FJ7LF55O
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AFP-464
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Breast Neoplasms
Unknown
AFP-464
×
Maximum Phase:
2
First Approval:
None
UNII:
73JNH95XPX
Molecule Type:
Small molecule
Molecular Formula:
C26H35F3N4O9S2
Molecular Weight:
668.71
AlogP:
3.94
PSA:
137.37
HBD:
4.0
HBA:
#RotB:
9.0
Source:
IFIDANCITINIB
2
Small molecule
Investigational
Unknown
Unknown
Dermatitis, Atopic
Unknown
IFIDANCITINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
R105E71J13
Molecule Type:
Small molecule
Molecular Formula:
C20H18FN5O3
Molecular Weight:
395.39
AlogP:
4.16
PSA:
105.07
HBD:
3.0
HBA:
#RotB:
5.0
Source:
SISUNATOVIR
2
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Fusion glycoprotein F0 inhibitor
SISUNATOVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
KE63TTO7WK
Molecule Type:
Small molecule
Molecular Formula:
C23H22F4N4O
Molecular Weight:
446.45
AlogP:
4.56
PSA:
64.15
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AZD-7624
2
Small molecule
Investigational
Unknown
Unknown
Inflammation; Asthma; Pulmonary Disease, Chronic Obstructive
MAP kinase p38 alpha inhibitor
AZD-7624
×
Maximum Phase:
2
First Approval:
None
UNII:
3P4CR02JTD
Molecule Type:
Small molecule
Molecular Formula:
C25H22N2O
Molecular Weight:
366.46
AlogP:
5.78
PSA:
41.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TANSHINONE IIA SULFONATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TANSHINONE IIA SULFONATE
×
Maximum Phase:
2
First Approval:
None
UNII:
5CKR8JG9OW
Molecule Type:
Small molecule
Molecular Formula:
C19H17NaO6S
Molecular Weight:
396.4
AlogP:
3.49
PSA:
101.65
HBD:
1.0
HBA:
#RotB:
1.0
Source:
Q203
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
Q203
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APX-3330
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
DNA-(apurinic or apyrimidinic site) lyase inhibitor
APX-3330
×
Maximum Phase:
2
First Approval:
None
UNII:
11267UI968
Molecule Type:
Small molecule
Molecular Formula:
C21H30O6
Molecular Weight:
378.47
AlogP:
4.11
PSA:
89.9
HBD:
1.0
HBA:
#RotB:
12.0
Source:
AZD-3759
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor erbB1 inhibitor
AZD-3759
×
Maximum Phase:
2
First Approval:
None
UNII:
67SX9H68W2
Molecule Type:
Small molecule
Molecular Formula:
C22H23ClFN5O3
Molecular Weight:
459.91
AlogP:
4.31
PSA:
79.82
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PTEROSTILBENE
2
Small molecule
Investigational
Unknown
Unknown
Acute Kidney Injury; Endometrial Hyperplasia; Endometrial Neoplasms
Unknown
PTEROSTILBENE
×
Maximum Phase:
2
First Approval:
None
UNII:
26R60S6A5I
Molecule Type:
Small molecule
Molecular Formula:
C16H16O3
Molecular Weight:
256.3
AlogP:
3.58
PSA:
38.69
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MIRAMISTIN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIRAMISTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
QL5J8F55LH
Molecule Type:
Small molecule
Molecular Formula:
C26H47ClN2O
Molecular Weight:
439.13
AlogP:
6.47
PSA:
29.1
HBD:
1.0
HBA:
#RotB:
18.0
Source:
MIBAMPATOR
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Glutamate receptor ionotropic AMPA positive allosteric modulator
MIBAMPATOR
×
Maximum Phase:
2
First Approval:
None
UNII:
A9V5BW73UU
Molecule Type:
Small molecule
Molecular Formula:
C21H30N2O4S2
Molecular Weight:
438.62
AlogP:
2.88
PSA:
92.34
HBD:
2.0
HBA:
#RotB:
10.0
Source:
JNJ-17166864
2
Small molecule
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal
Unknown
JNJ-17166864
×
Maximum Phase:
2
First Approval:
None
UNII:
VF9KM790TY
Molecule Type:
Small molecule
Molecular Formula:
C21H25Cl2N2O2+
Molecular Weight:
408.35
AlogP:
5.0
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PICEID
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PICEID
×
Maximum Phase:
2
First Approval:
None
UNII:
XM261C37CQ
Molecule Type:
Small molecule
Molecular Formula:
C20H22O8
Molecular Weight:
390.39
AlogP:
0.45
PSA:
139.84
HBD:
6.0
HBA:
#RotB:
5.0
Source:
VERINURAD
2
Small molecule
Investigational
Unknown
Unknown
Gout; Heart Failure; Hyperuricemia; Renal Insufficiency, Chronic
Solute carrier family 22 member 12 inhibitor
VERINURAD
×
Maximum Phase:
2
First Approval:
None
UNII:
12WJ62D047
Molecule Type:
Small molecule
Molecular Formula:
C20H16N2O2S
Molecular Weight:
348.43
AlogP:
4.73
PSA:
73.98
HBD:
1.0
HBA:
#RotB:
4.0
Source:
VIPIVOTIDE TETRAXETAN GALLIUM GA-68
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
VIPIVOTIDE TETRAXETAN GALLIUM GA-68
×
Maximum Phase:
2
First Approval:
None
UNII:
7P5C02S4X8
Molecule Type:
Small molecule
Molecular Formula:
C49H68GaN9O16
Molecular Weight:
1107.06
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
POLYDEXTROSE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
POLYDEXTROSE
×
Maximum Phase:
2
First Approval:
None
UNII:
VH2XOU12IE
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NM404
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NM404
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
WNT-974
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Squamous Cell
Probable protein-cysteine N-palmitoyltransferase porcupine inhibitor
WNT-974
×
Maximum Phase:
2
First Approval:
None
UNII:
U27F40013Q
Molecule Type:
Small molecule
Molecular Formula:
C23H20N6O
Molecular Weight:
396.45
AlogP:
3.79
PSA:
93.55
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LY-2090314
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Pancreatic Neoplasms; Leukemia
Glycogen synthase kinase-3 alpha inhibitor
LY-2090314
×
Maximum Phase:
2
First Approval:
None
UNII:
822M3GYM67
Molecule Type:
Small molecule
Molecular Formula:
C28H25FN6O3
Molecular Weight:
512.55
AlogP:
3.42
PSA:
91.95
HBD:
1.0
HBA:
#RotB:
2.0
Source:
JNJ-41443532
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
C-C chemokine receptor type 2 antagonist
JNJ-41443532
×
Maximum Phase:
2
First Approval:
None
UNII:
0OJB0LES1A
Molecule Type:
Small molecule
Molecular Formula:
C22H25F3N4O3S
Molecular Weight:
482.53
AlogP:
2.52
PSA:
94.56
HBD:
3.0
HBA:
#RotB:
6.0
Source:
PF-00489791
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Nephropathies; Hypertension; Hypertension, Pulmonary; Raynaud Disease
Phosphodiesterase 5A inhibitor
PF-00489791
×
Maximum Phase:
2
First Approval:
None
UNII:
2S27T3DSZ3
Molecule Type:
Small molecule
Molecular Formula:
C20H28N8O4S
Molecular Weight:
476.56
AlogP:
1.46
PSA:
144.23
HBD:
2.0
HBA:
#RotB:
10.0
Source:
ORM-12741
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
ORM-12741
×
Maximum Phase:
2
First Approval:
None
UNII:
D26C95A960
Molecule Type:
Small molecule
Molecular Formula:
C18H23NO2
Molecular Weight:
285.39
AlogP:
3.78
PSA:
25.61
HBD:
0.0
HBA:
#RotB:
2.0
Source:
1
2
…
98
99
100
101
102
103
104
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA